|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Chromosomal Microarray, Solid Tumor FFPE, Clarisure® Oligo-SNP
Test Code38842
CPT Codes
81277
Preferred Specimen
5x5 mm tissue in formalin-fixed, paraffin-embedded block
Minimum Volume
2x3 mm tissue block
Other Acceptable Specimens
5 unstained (4-6 micron sections), positively charged slides
Instructions
Formalin-fixed, paraffin-embedded tissue or charged/+slides from formalin fixed, paraffin embedded tissue. Specimen MUST be fixed in 10% neutral buffered formalin. Cold ischemic time of less than 1 hour and fixation between 6 and 72 hours is recommended.
Pathology report must be supplied with sample. Ship at room temperature. Do not freeze.
Send specimen to testing lab for viability determination. Do not reject.
Pathology report must be supplied with sample. Ship at room temperature. Do not freeze.
Send specimen to testing lab for viability determination. Do not reject.
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 5 years
Refrigerated: 5 years
Frozen: Unacceptable
Refrigerated: 5 years
Frozen: Unacceptable
Methodology
Oligo-SNP Array
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 15 days
Reference Range
Interpretive report
Clinical Significance
To integrate the microarray in the investigation of neoplasms to assess genomic alterations and overall genomic complexity of the abnormal clone. To be used in conjunction with other established clinical laboratory tests for the malignancy in question.